| 序号 |
商品名 |
申请号 |
产品号 |
申请类型 |
活性成分 |
剂型 |
规格 |
参比药物 |
参比标准 |
申请号批准日期 |
产品号批准日期 |
申请人 |
市场状态 |
| 1 |
OXCARBAZEPINE |
209020 |
1 |
ANDA |
OXCARBAZEPINE |
SUSPENSION;ORAL |
300MG/5ML |
No |
No |
2026-05-29 |
2026-05-29 |
MSN |
Prescription |
| 2 |
CAVHANZA |
217379 |
1 |
NDA |
NILOTINIB |
TABLET, ORALLY DISINTEGRATING;ORAL |
60MG |
Yes |
No |
2026-05-29 |
2026-05-29 |
FLEX PHARMA |
Prescription |
| 3 |
CAVHANZA |
217379 |
2 |
NDA |
NILOTINIB |
TABLET, ORALLY DISINTEGRATING;ORAL |
80MG |
Yes |
Yes |
2026-05-29 |
2026-05-29 |
FLEX PHARMA |
Prescription |
| 4 |
XOCOVA |
220442 |
1 |
NDA |
ENSITRELVIR |
TABLET;ORAL |
125MG |
Yes |
Yes |
2026-05-29 |
2026-05-29 |
SHIONOGI |
Prescription |
| 5 |
EPINEPHRINE |
220562 |
1 |
ANDA |
EPINEPHRINE |
SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
1MG/ML (1MG/ML) |
No |
No |
2026-05-29 |
2026-05-29 |
HIKMA |
Prescription |
| 6 |
ZAYNICH |
220787 |
1 |
NDA |
CEFEPIME HYDROCHLORIDE; ZIDEBACTAM |
POWDER;INTRAVENOUS |
EQ 2GM BASE/VIAL;1GM/VIAL |
Yes |
Yes |
2026-05-29 |
2026-05-29 |
WOCKHARDT BIO AG |
Prescription |
| 7 |
SODIUM SULFATE, MAGNESIUM SULFATE AND POTASSIUM CHLORIDE |
216095 |
1 |
ANDA |
MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM SULFATE |
TABLET;ORAL |
0.225GM;0.188GM;1.479GM |
No |
No |
2026-05-28 |
2026-05-28 |
LUPIN |
Prescription |
| 8 |
DEFLAZACORT |
220709 |
1 |
ANDA |
DEFLAZACORT |
SUSPENSION;ORAL |
22.75MG/ML |
No |
No |
2026-05-28 |
2026-05-28 |
CARNEGIE |
Prescription |
| 9 |
LINAGLIPTIN |
208433 |
1 |
ANDA |
LINAGLIPTIN |
TABLET;ORAL |
5MG |
No |
No |
2026-05-27 |
2026-05-27 |
TEVA PHARMS USA |
Prescription |
| 10 |
CARBOPROST TROMETHAMINE |
219529 |
1 |
ANDA |
CARBOPROST TROMETHAMINE |
INJECTABLE;INJECTION |
EQ 0.25MG BASE/ML |
No |
No |
2026-05-27 |
2026-05-27 |
SOMERSET THERAPS LLC |
Prescription |